Curanex Pharmaceuticals Inc Common Stock (CURX)

Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters

Curanex Pharmaceuticals completed its initial public offering by having Dominari Securities fully exercise the over-allotment option, raising an additional $2.25 million and bringing total gross proceeds to $17.25 million through the issuance of 4,312,500 shares at $4.00 per share.